BSYN Biosynergy Inc
Company profile
Ticker
BSYN
Exchange
Employees
Incorporated in
Location
Fiscal year end
Industry (SEC)
SEC CIK
Corporate docs
IRS number
362880990
Calendar
2 Aug 19
22 Aug 19
30 Apr 20
News
Company financial data Financial data
| Quarter (USD) | Apr 19 | Jan 19 | Apr 18 | Jan 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Net income | -16.26K | 53.36K | -56.63K | 5.1K | |
| Diluted EPS | -0 | 0 | 0 | .000 | |
| Net profit margin | |||||
| Operating income | -23.39K | 74.02K | -2.08K | 6.46K | |
| Net change in cash | 5.48K | 34.22K | 7.74K | 25.7K | |
| Cash on hand | 1.18M | 1.17M | 1.14M | 1.13M |
| Annual (USD) | Apr 19 | Apr 18 | Apr 17 | Apr 16 | |
|---|---|---|---|---|---|
| Revenue | 1.29M | 1.21M | 1.29M | 1.34M | |
| Net income | 73.49K | 33.11K | 107.23K | 106.27K | |
| Diluted EPS | 0.01 | 0 | .007 | 0.01 | |
| Net profit margin | 5.69% | 2.73% | 8.30% | 7.94% | |
| Operating income | 100.33K | 32.4K | 148.59K | 145.16K | |
| Net change in cash | 39.7K | 99.85K | -51.07K | 115.87K | |
| Cash on hand | 1.18M | 1.14M | 1.04M | 1.09M |
Financial data from Biosynergy earnings reports
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
7th grade Avg
|
|
New words:
adjustment, advertising, asset, attributable, Ave, calculated, clarifying, Codification, component, condensed, discount, HemoCool, HemoCoolTMGel, Kennicott, recast, recover, recovery, ROU, treatment, unchanged
Removed:
appeal, approximate, base, certify, cooler, economically, exhibit, full, fully, light, misleading, Notice, occurred, omit, refrigerated, rejected, shipment, Street, summarize, transportation, untrue, viable
Financial reports
10-K/A
2019 FY
Annual report (amended)
2 Aug 19
10-K
2019 FY
Annual report
25 Jul 19
10-Q
2019 Q3
Quarterly report
14 Mar 19
10-Q/A
2019 Q2
Quarterly report (amended)
20 Dec 18
10-Q
2019 Q2
Quarterly report
17 Dec 18
10-Q
2019 Q1
Quarterly report
14 Sep 18
10-K
2018 FY
Annual report
20 Jul 18
10-Q
2018 Q3
Quarterly report
19 Mar 18
10-Q
2017 Q2
Quarterly report
15 Dec 17
10-Q
2018 Q1
Quarterly report
13 Sep 17
Current reports
8-K
Departure of Directors or Certain Officers
31 May 18
8-K
Departure of Directors or Certain Officers
12 Jul 17
8-K
Financial Statements and Exhibits
8 Jan 13
8-K
Financial Statements and Exhibits
28 Aug 09
8-K
Amendments to Articles of Incorporation or Bylaws
2 Jul 09
8-K
Financial Statements and Exhibits
15 Nov 06
8-K
Financial Statements and Exhibits
30 Jun 06
8-K
Entry into a Material Definitive Agreement
14 Dec 04
Registration and prospectus
No filings
Proxies
No filings